Stock analysts at StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the stock.
SenesTech Price Performance
SNES stock opened at $0.76 on Wednesday. SenesTech has a 1 year low of $0.52 and a 1 year high of $19.20. The firm has a 50-day moving average of $0.78 and a 200 day moving average of $1.40. The company has a debt-to-equity ratio of 0.02, a current ratio of 8.49 and a quick ratio of 7.48.
Hedge Funds Weigh In On SenesTech
A hedge fund recently bought a new stake in SenesTech stock. Armistice Capital LLC acquired a new position in SenesTech, Inc. (NASDAQ:SNES – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 70,425 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned 1.94% of SenesTech at the end of the most recent reporting period. Hedge funds and other institutional investors own 5.19% of the company’s stock.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- What is an Earnings Surprise?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- How to Invest in Insurance Companies: A Guide
- Hilton Demonstrates Asset Light is Right for Investors
- What is the Dow Jones Industrial Average (DJIA)?
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
